Human cytomegalovirus (CMV) is the most common nongenetic cause of congenital disability. As a herpesvirus that infects the majority of the population, CMV is able to estab- 
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Human CMV infection
Human CMV is a member of the Herpesviridae family of viruses, which includes Herpes simplex virus type 1 Approximately 1-2% of initially uninfected pregnant women will acquire CMV by the time of delivery 12 . A possible source of CMV for these women is young children whose saliva and urine contain high levels of CMV 13 . In addition, a partner who is infected with CMV is an additional possible risk factor for infection during pregnancy, as CMV is present in semen, and can be transmitted sexually 12 . Among the women who acquire a primary infection during pregnancy 32% transmit CMV to the foetus via the placenta, resulting in congenital CMV (cCMV) infection 14 . Only a percentage of cCMV infected children will exhibit symptoms at birth or develop CMV associated symptoms later in life, as further described in detail below.
The foetus can also be infected by a woman's latent virus or reinfection with a different strain of CMV (secondary infection) 15 . The risk of transmitting CMV to the foetus is reported to be higher when a pregnant woman acquires a primary infection during the first half of the pregnancy compared to secondary infections, or infection in the second half of pregnancy 16 . 14, [18] [19] [20] , this translates to an estimated~0.12 million cCMV infections in developed countries per year, and~0.7 million to 4.5 million cCMV infections annually in developing countries.
Particularly in Australia, an estimated~2000 children are born with cCMV infection in Australia each year (Table 1) . Nonetheless, in practice, most congenital CMV infections remain undiagnosed 18 .
Clinical features of maternal CMV infection
The majority of CMV infections in immunocompetent individuals do not cause symptoms; however, clinical manifestations could include glandular fever (mononucleosis) syndrome characterised by flu-like symptoms, or occasionally persistent fever 24 . Several studies reported that pregnant women, who acquired a primary CMV infection, experienced mononucleosis, fever, fatigue, and 
Clinical features of congenital cytomegalovirus disease
A minority (~10%) of cCMV infected children present symptoms at birth (Table 2) . Physical signs such as petechiae, jaundice, and hepatosplenomegaly are common and have been observed in 28
to 50% of children with cCMV infection 18, 27 . Neurological abnormality, including microcephaly and intracranial calcification has been reported to occur in 18-38% of cCMV infected children.
The majority of these affected children develop sensorineural hearing loss, mental disability, motor deficits, chorioretinitis and seizures 16, 23, 26 .
A significant amount (~15%) of initially asymptomatic CMV infected children will encounter developmental difficulties, neurological problems, or hearing loss before the age of five 9,18,28 . Among those with hearing loss~40% of children may develop severe to profound Congenital CMV infection may also result in adverse pregnancy outcomes, as cCMV has been associated with fetal death in utero, neonatal death, preterm birth and maternal pregnancy complications, including preeclampsia [29] [30] [31] [32] [33] .
Concluding remarks
CMV continues to be the leading infectious cause of congenital malformation in developed countries. More children may be affect- 
Established anti-CMV therapeutics

Valaciclovir
To date, the only established CMV antiviral to undergo investigations during pregnancy is valaciclovir, the prodrug of the nucleoside
